US group transfers pharmaceutical production technology to Vietnam
US-based Pfizer Group, one of the world's premier biopharmaceutical companies, has signed an agreement on the transfer of pharmaceutical production technology to Vietnamese enterprises, so first products are scheduled to be produced in 2020.
National Assembly Vice Chairman Phung Quoc Hien (R) receives Pfizer Group's Regional President for Asia and Emerging Markets Pierre Gaudreault (Source: VNA)Hanoi (VNA) – US-based Pfizer Group, one of the world's premier biopharmaceutical companies, has signed an agreement on the transfer of pharmaceutical production technology to Vietnamese enterprises, so first products are scheduled to be produced in 2020.
The information was made by the group’s Regional President for Asia and Emerging Markets Pierre Gaudreault in a meeting with Vietnam’s National Assembly Vice Chairman Phung Quoc Hien in Hanoi on January 10.
Pierre Gaudreault affirmed that the signing of the deal shows Pfizer’s commitment to long-term investment in Vietnam, thus contributing to the country’s pharmaceutical industry and applying technology with international standard in its drug production.
According to him, the group decided to invest in Vietnam as it sees potential of the Vietnamese market and its surrounding areas as well as the country’s open investment policies.
He pledged to share the group’s best experiences with Vietnamese enterprises, while hoping that the Vietnamese Government will continue creating conditions on policies and procedures for the group to expand its presence in the country.
NA Vice Chairman Phung Quoc Hien stated that the transfer of technology is a breakthrough in the two sides’ cooperation. This not only is a good chance for Vietnam’s pharmaceutical producers to improve their capacity, but also helps Vietnamese people buy high-quality drugs at reasonable prices.
He suggested Pfizer study Vietnam’s climate to produce types of drugs that are suitable to Vietnamese and Southeast Asian markets.
He affirmed that Vietnam will facilitate investment of foreign enterprises, including Pfizer.-VNA
You should also see
Semiconductor workforce development a breakthrough: PM
Human resources development in semiconductors should be considered a breakthrough in personnel training, Prime Minister Pham Minh Chinh said at a conference in Hanoi on April 24.
See more
Health
First int’l symposium on medicinal plants, natural compounds held in Binh Dinh
The first Vietnam International Symposium on Medicinal Plants and Natural Compounds was held in the south central province of Binh Dinh from April 15-17, with nearly 120 delegates, including speakers, scientists and researchers from 13 countries taking part.
Health
Vietnam has first int’l trauma life support training centre
The International Trauma Life Support (ITLS) Training Centre under the Ministry of National Defence’s Military Hospital 175 officially made its debut in Hanoi on April 15. This is the first of its kind in Vietnam and the fifth established in Southeast Asia.
Health
Vietnam has first int’l trauma life support training centre
The International Trauma Life Support (ITLS) Training Centre under the Ministry of National Defence’s Military Hospital 175 officially made its debut in Ho Chi Minh City on April 15.
Health
First southern pediatric organ transplant centre to become operational in 2025
The first pediatric organ transplant centre in Vietnam’s southern region is scheduled to be completed and put into operation on the occasion of the 50th anniversary of the Liberation of the South and National Reunification Day (April 30, 1975 - 2025).
Health
Free surgeries offered for cleft palate children in Thua Thien-Hue
About 80 children with cleft palate in the central province of Thua Thien-Hue and surrounding localities are to receive free check-ups and surgeries from now until April 18.
